Barclays PLC Cytokinetics Inc Call Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$51.22 - $60.16 $3.59 Million - $4.21 Million	-70,000 Reduced 87.5%	10,000 $528,000
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $2.49 Million - $3.9 Million	52,000 Added 185.71%	80,000 $4.33 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $43.2 Million - $73.2 Million	-677,800 Reduced 96.03%	28,000 $1.96 Million
Q4 2023 Feb 15, 2024	BUY	$26.88 - $83.49 $18.5 Million - $57.4 Million	688,000 Added 3865.17%	705,800 $58.9 Million
Q3 2023 Nov 07, 2023	BUY	$29.46 - $36.61 $524,388 - $651,658	17,800 New	17,800 $524,000
Q3 2020 Nov 12, 2020	SELL	$20.58 - $28.96 $926,099 - $1.3 Million	-45,000 Reduced 89.11%	5,500 $119,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $606,000 - $757,500	50,500	50,500 $732,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.39B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.